ArticleSignal transduction and targeted therapy2025

Integrative analysis of non-small cell lung cancer identifies Jumonji domain-containing 6/ETS homologous factor axis as a target to overcome radioresistance.

Manni Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.